Global Senior Director Medical Affairs (GDMA) -- Gyn

Role Summary: The Global Senior Director Medical Affairs (GDMA) is a subject matter expert in their area of responsibility (eg, defined tumor, asset, vaccine) and responsible for driving execution of the Global Medical and Scientific Affairs (GMSA) portion for their assigned Therapeutic Areas (TA) as part of the Global Value & Implementation (V&I) Plans. As a highly specialized SME, they bring business savviness to the organization, are important decision makers and will have a focus on the US, while also supporting the Rest of the World (ROW). The GDMA may also be appointed as a V&I Lead for their disease/asset area, which includes additional organizationally aligned responsibilities. The GDMA works as part of a high-performing, results driven team, focused on executional excellence. Responsibilities and Primary Activities: Drives execution of the annual V&I plan with medical affairs colleagues from key countries and regions with a focus on the US. Acts as an empowered partner, making informed decisions with a strategic and agile mindset. Serves as the subject matter expert (SME) and connector across assigned therapeutic areas, translating global scientific platforms into actionable Medical Value Narratives (MVNs). The GDMA actively engages with country-level stakeholders—including medical advisors, payers, and scientific leaders—to ensure strategic alignment and support local data generation, congress planning, and advisory boards Serves as the medical representative within Product Development sub-teams (including Clinical, V&I, Commercial, Publications, and Label), leveraging the GMSA vision to drive strategic planning, outcome delivery, and tactical execution. Communicates pertinent information to stakeholders (e.g., Executive Director Medical Affairs (EDMA), Regional Strategy Leads (RSL), Regional Director Medical Affairs (RDMA), US Director Medical Affairs (US DMA), Payor and Access Strategy Leads (PASLs)) to inform and influence country and regional planning. Acts as the subject matter expert, collaborating closely with V&I Outcomes Research (VIOR), Policy, Commercial, and Market Access teams to identify and address opportunities and barriers in key countries. Serves as a strategic partner for Big Country Markets (US, China, Japan) with no RDMA role. Plays a pivotal role in bridging global strategy with local execution, including understanding the needs of the US Market. Proactively collaborates with USDMA and equivalent roles in China and Japan, ensuring that country-specific insights are integrated into the global V&I plans and that global strategies are contextualized for local relevance. Consolidates actionable medical insights from countries and regions. Engages with a network of international scientific leaders and other key stakeholders (therapeutic guideline committees, payers, public groups, government officials, medical societies) about Our Company’s emerging science, building an important network and partnership internally and externally. Monitors external changing environment in partnership with the competitive intelligence (CI) team. Organizes global expert input events (advisory boards and expert input forums) to answer Our Company’s questions about how to develop and implement new medicines or vaccines. Collaborate with Global Human Health (commercial) executive directors to inform of the GMSA portion of V&I plans to ensure alignment, while independently leading the execution of these plans. Organizes global symposia and educational meetings. Supports key countries with the development of local data generation study concepts and protocols when requested. Reviews Investigator-Initiated Study proposals from key countries prior to headquarters submission (ex-USA) and in collaboration with RDMAs, while also serving as a review panel member on TA specific MISP’s to support the EDSA review process. Manages programs (patient support, educational or risk management) to support